HHealth Read More Targeting senescent fat cells provides new hope for ovarian cancerApril 13, 2026 Ovarian cancer is the most lethal malignancy of the female reproductive system. Due to its insidious early symptoms…
HHealth Read More JMIR Publications’ new article showcases the transformative potential of precision oncologyApril 6, 2026 JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…
HHealth Read More Tumor microenvironment drives resistance to ferroptosis in pancreatic cancerApril 3, 2026 Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can…
HHealth Read More Microbial ecosystems influence success of cancer checkpoint immunotherapyMarch 9, 2026 Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies.…
TTechnology Read More Remote-controlled CAR T cells offer safer cancer therapyFebruary 20, 2026 Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells…
HHealth Read More Engineered Listeria boosts innate immunity against cancerFebruary 14, 2026 After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system…
TTechnology Read More Tumor-targeted chimeric drug increases efficacy and limits side effectsFebruary 8, 2026 Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
TTechnology Read More ERC Proof of Concept grant supports promising CRISPR-based cancer treatment researchJanuary 31, 2026 Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept…
HHealth Read More Reframing the role of MCL1 in cancer signaling and metabolismDecember 23, 2025 A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD…
HHealth Read More AR3-based optogenetic strategy shows high efficacy in inducing apoptosis and antitumor effectsDecember 2, 2025 One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through…
TTechnology Read More The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy | Molecular CancerNovember 7, 2025 Bernadotte A, Mikhelson VM, Spivak IM. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence.…
SScience Read More CRATERs identified as key sites for T cell-mediated tumor destructionOctober 18, 2025 Like the surface of the moon, new research published today in Cell finds the existence of craters on…